
The National Medical Products Administration held a promotion meeting for brain-computer interface medical devices. The meeting emphasized the need to prioritize safety and effectiveness, establish a standard system, and strengthen technical guidance services. It also called for enhanced cross-departmental collaboration, bringing together industry, academia, research, and medical professionals to jointly address key technical challenges and improve the industrial and supply chains. Enterprises were urged to take primary responsibility, enhance product reliability and overall competitiveness, and actively promote the faster and better clinical application of brain-computer interface devices.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
